Lymphomas: ly-01

LY-01. Myeloid-derived supressor cells and their suppressive potential after autologous hematopoietic stem cell transplantation in patients with multiple myeloma

Tatyana A. Aristova, Tamara V. Tyrinova, Egor V. Batorov, Vera V. Denisova, Svetlana A. Sizikova, Galina Yu. Ushakova, Ekaterina Y. Shevela, Alexander A. Ostanin, Elena R. Chernykh

LY-02. Treatment strategy of patients with relapsed and refractory aggressive B-cell non-Hodgkin lymphoma

Liudmila V. Fedorova, Olesya G. Smykova, Andrey M. Chekalov, Marina O. Popova, Vladislav V. Markelov, Elena V. Kondakova, Ivan S. Moiseev, Kirill V. Lepik, Natalia B. Mikhailova, Alexander D. Kulagin

LY-03. Long-term multicenter study of nivolumab efficacy and safety in patients with relapsed and refractory classic Hodgkin lymphoma

Yaroslava V. Komarova¹, Ludmila V. Fedorova¹, Marina V. Demchenkova², Maria V. Grigorieva², Polina V. Kotselyabina¹, Andrey M. Chekalov¹, Elena E. Lepik¹, Elena V. Kondakova¹, Evgenia S. Borzenkova¹, Vadim V. Baykov¹, Marina O. Popova¹, Ivan S. Moiseev¹, Kirill V. Lepik¹, Natalia B. Mikhailova¹, Alexander D. Kulagin¹

LY-04. Prospective study: autologous hematopoietic stem cell transplantation in patients with HIV-related lymphoma

Marina O. Popova, Yuliya A. Rogacheva, Andrey M. Chekalov, Ivan V. Tsygankov, Kirill V. Lepik, Lilia V. Stelmakh, Vadim V. Baykov, Natalia B. Mikhailova, Alexander D. Kulagin

LY-05. Comparison of toxicity and efficacy of BeEAC, LEAM, and CLV conditioning regimens before autologous stem cell transplantation for treatment of primary-refractory and relapsed forms of Hodgkin’s lymphoma

Anastasiia A. Samoylova, Vladislav O. Sarzhevskiy, Vladimir Ya. Melnichenko, Nikita E. Mochkin, Anatoliy A. Rukavitsyn, Elena G. Smirnova, Vladimir S. Bogatyrev, Anna E. Bannikova

LY-06. Quality control of peripheral hematopoietic blood stem cells transplants obtained by G-CSF and plerixafor-induced mobilization in patients with multiple myeloma

Zarui K. Simavonyan, Anait D. Davtyan, Irina V. Kobzeva, Tatiana A. Astrelina, Yuliya B. Suchkova, Elena K. Sokolova

LY-07. Immunochemotherapy with nivolumab, bendamustine, gemcitabine and rituximab (BeGeRN) in relapsed or refractory B-cell Non-Hodgkin Lymphoma: NCT03259529

Olesya G. Smykova, Vladislav V. Markelov, Kirill V. Lepik, Elena V. Kondakova, Lilia V. Stelmakh, Ivan S. Moiseev, Natalia B. Mikhailova, Alexander D. Kulagin

LY-08. First-line therapeutic strategy and clinical prognosis in the patients with marginal zone lymphoma: Pavlov University experience

Lina B. Surina, Polina V. Kotselyabina, Kirill V. Lepik, Elena V. Kondakova, Liudmila V. Fedorova, Marina O. Popova, Natalia B. Mikhailova, Alexander D. Kulagin

Lymphomas: LY-01 – LY-08